| Survival: | 8.7 months |
| Toxicity Grade: | 1 |
| Treatments: | Radiation |
| Drugs: | |
| Country: | Australia |
| City/State/Province: | Perth |
| Hospital: | Sir Charles Gairdner Hospital |
| Journal: | Link |
| Date: | 7/2004 |
| Description: |
| Patients: This study involved 43 patients with malignant pleural mesothelioma. Only a subset of patients were administered the radiotherapy treatment. Treatment: The treatment consisted of a single-dose of radiotherapy to prevent the metastasis that often takes place (i.e. 19% of the time) in the chest wall after a thoracoscopy. Toxicity: Toxicities were described as mild with nothing over grade 1. Results: There was no statistical difference in metastasis between the patients that received the radiotherapy, and those that did not. The overall median survival was 8.7 months. Correspondence: Dr. S. Bydder |